Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT AGITATION II – clonidine in children ≤1 year
2020-005409-26Phase 2Active
- Sponsor
- Rigshospitalet
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of clonidine in Emergence agitation (EA) and agitation, sponsored by Rigshospitalet. Primary endpoint: Pharmacokinetics of clonidine. Started Mar 2021; status: active.
02
Drugs
clonidine
03
Conditions
Emergence agitation (EA)agitation
Beyond the preview
Go deeper on 2020-005409-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005409-26.